<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clascoterone: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clascoterone: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Clascoterone: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="129396" href="/d/html/129396.html" rel="external">see "Clascoterone: Drug information"</a> and <a class="drug drug_patient" data-topicid="129444" href="/d/html/129444.html" rel="external">see "Clascoterone: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F55175785"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Winlevi</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F58765946"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Winlevi</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F54863720"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Androgen Receptor Inhibitor</span></li></ul></div>
<div class="block dop drugH1Div" id="F54795454"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b> Children ≥12 years and Adolescents: Topical: Apply thin layer to the affected area twice daily, in the morning and the evening.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F54795455"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F54795456"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F54861880"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="129396" href="/d/html/129396.html" rel="external">see "Clascoterone: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris (alternative agent): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Reserve for patients in whom initial topical therapies fail; for moderate to severe acne, may be used as part of an appropriate combination regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26897386','lexi-content-ref-Graber.2','lexi-content-ref-Graber.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26897386','lexi-content-ref-Graber.2','lexi-content-ref-Graber.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical:</b> Apply thin layer to affected areas of skin twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32320027']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32320027'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F54861881"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F54861882"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block arsc drugH1Div" id="F55493675"><span class="drugH1">Adverse Reactions (Significant): Considerations</span>
<div class="collapsible">
<span class="collapsible-title">Adrenal suppression</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Reversible hypothalamic-pituitary-adrenal axis suppression (<b>HPA-axis suppression</b>) has been observed with clascoterone therapy.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Dose-related; related to the pharmacologic action (androgen receptor inhibitor).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Varied; in a pharmacokinetic trial, laboratory evidence of HPA-axis suppression was observed 2 weeks after initiation of therapy and in these subjects returned to normal 4 weeks after therapy discontinuation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31251549']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31251549'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">• Children and adolescents (may be more susceptible)</p>
<p style="text-indent:-2em;margin-left:6em;">• Application to large surface areas</p>
<p style="text-indent:-2em;margin-left:6em;">• Prolonged use</p>
<p style="text-indent:-2em;margin-left:6em;">• Use of occlusive dressings</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F54841782"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Dermatologic: Exfoliation of skin, xeroderma</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Dermatologic: Atrophic striae (3%)</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined:</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Amenorrhea, HPA-axis suppression (Mazzetti 2019), hyperkalemia</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Polycystic ovary syndrome</p></div>
<div class="block coi drugH1Div" id="F54788682"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F54861872"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Local effects: Local adverse reactions may occur (eg, erythema, redness, pruritus, dryness, scaling) during treatment. Use with concomitant topical products (eg, medicated or abrasive soaps and cleansers, soaps and cosmetics with a strong drying effect, products with high concentrations of alcohol, astringents, spices, or limes) should be limited.</p>
<p style="text-indent:-2em;margin-left:4em;">• Systemic effects: Absorption is increased by the use of occlusive dressings, application to large surface areas, or prolonged use.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Special populations:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For external use only; not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes, mouth, and other mucous membranes. Not for use on eczematous, abraded, broken, or sunburned skin.</p></div>
<div class="block foc drugH1Div" id="F55175786"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Winlevi: 1% (60 g) [contains cetyl alcohol, edetate (edta) disodium, polysorbate 80, propylene glycol]</p></div>
<div class="block geq drugH1Div" id="F55175784"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F55195458"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Winlevi External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $11.66</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F58765947"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Winlevi: 1% (2 g, 10 g, 30 g, 60 g) [contains cetyl alcohol, edetate (edta) disodium, polysorbate 80, propylene glycol]</p></div>
<div class="block admp drugH1Div" id="F54795457"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For topical use only; not for oral, ophthalmic, or intravaginal use. Gently wash and dry the affected area, then apply a thin, uniform layer. Avoid eyes, mouth, or other mucous membranes; rinse thoroughly with water if contact occurs. Do not apply to eczematous, abraded, broken, or sunburned skin.</p></div>
<div class="block adm drugH1Div" id="F54861883"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Topical:</b> Clean and dry skin before applying. For topical external use only; not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes, mouth, or other mucous membranes; rinse thoroughly if accidental contact with these areas occurs. Avoid use on cuts, abrasions, and eczematous or sunburned skin.</p></div>
<div class="block sts drugH1Div" id="F54861876"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Prior to dispensing, store in refrigerator between 2°C and 8°C (36°F and 46°F); do not freeze. Once dispensed, store at room temperature between 20°C and 25°C (68°F and 77°F). Do not freeze. Discard the unused product 180 days after the date of dispensing or 1 month after first opening, whichever is sooner.</p></div>
<div class="block usep drugH1Div" id="F54788727"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Topical treatment of acne vulgaris (FDA approved in ages ≥12 years and adults).</p></div>
<div class="block cyt drugH1Div" id="F54802812"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F54802809"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F54861870"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events were observed in some animal reproduction studies following subcutaneous administration. Information related to topical clascoterone exposure in pregnancy is limited. Pregnant patients were excluded from the initial clinical studies and patients were removed from the trial once pregnancy was confirmed (Eichenfield 2020; Hebert 2020).</p></div>
<div class="block mopp drugH1Div" id="F54795458"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Improvement of acne lesions; local skin irritation; hypothalamic pituitary adrenal (HPA) axis suppression.</p></div>
<div class="block pha drugH1Div" id="F54861877"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Clascoterone is an androgen receptor inhibitor that decreases sebum production and inflammation.</p></div>
<div class="block phk drugH1Div" id="F54861878"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Protein binding: 84% to 89%.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58216278"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Clascon</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Winlevi</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-32348828">
<a name="32348828"></a>Eichenfield L, Hebert A, Gold LS, et al. Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris. <i>J Am Acad Dermatol</i>. 2020;83(2):477-485. doi:10.1016/j.jaad.2020.04.087<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clascoterone-pediatric-drug-information/abstract-text/32348828/pubmed" id="32348828" target="_blank">32348828</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Graber.2">
<a name="Graber.2"></a>Graber E. Acne vulgaris: Management of moderate to severe acne in adolescents and adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed February 3, 2022a.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Graber.1">
<a name="Graber.1"></a>Graber E. Acne vulgaris: overview of management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed February 3, 2022b.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32320027">
<a name="32320027"></a>Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. <i>JAMA Dermatol</i>. 2020;156(6):621-630. doi:10.1001/jamadermatol.2020.0465<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clascoterone-pediatric-drug-information/abstract-text/32320027/pubmed" id="32320027" target="_blank">32320027</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31251549">
<a name="31251549"></a>Mazzetti A, Moro L, Gerloni M, Cartwright M. Pharmacokinetic profile, safety, and tolerability of clascoterone (cortexolone 17-alpha propionate, CB-03-01) topical cream, 1% in subjects with acne vulgaris: an open-label phase 2a study. <i>J Drugs Dermatol</i>. 2019;18(6):563.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clascoterone-pediatric-drug-information/abstract-text/31251549/pubmed" id="31251549" target="_blank">31251549</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Winlevi.1">
<a name="Winlevi.1"></a>Winlevi (clascoterone) [prescribing information]. Cranbury, NJ: Sun Pharmaceutical Industries Inc; December 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26897386">
<a name="26897386"></a>Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. <i>J Am Acad Dermatol</i>. 2016;74(5):945-973.e33. http://www.jaad.org/article/S0190-9622(15)02614-6/pdf. Accessed March 3, 2022.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clascoterone-pediatric-drug-information/abstract-text/26897386/pubmed" id="26897386" target="_blank">26897386</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 129405 Version 58.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
